A recent FDA clinical-grade urine-based assay for the non-coding transcript PCA3 (overexpressed in >95% of PCa) has demonstrated utility when combined with serum PSA for PCa detection (Loeb and Partin 2011). The gene discussed is KLK3; the disease is posterior cortical atrophy.